VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $131,307,000 | -25.8% | 5,650,057 | -49.2% | 0.71% | -30.2% |
| Q1 2018 | $176,995,000 | +110.3% | 11,117,780 | +174.5% | 1.02% | +148.2% |
| Q4 2017 | $84,152,000 | +46.7% | 4,049,900 | +1.2% | 0.41% | +44.5% |
| Q3 2017 | $57,362,000 | +199.2% | 4,003,422 | +261.2% | 0.28% | +141.9% |
| Q2 2017 | $19,174,000 | +320.2% | 1,108,470 | +167.9% | 0.12% | +265.6% |
| Q1 2017 | $4,563,000 | -21.4% | 413,693 | +3.4% | 0.03% | -22.0% |
| Q4 2016 | $5,805,000 | -49.2% | 400,100 | -14.0% | 0.04% | -44.6% |
| Q3 2016 | $11,416,000 | +60.4% | 465,223 | +31.5% | 0.07% | +54.2% |
| Q2 2016 | $7,119,000 | -1.4% | 353,829 | +29.2% | 0.05% | -25.0% |
| Q1 2016 | $7,219,000 | -40.7% | 273,901 | +128.6% | 0.06% | -45.8% |
| Q4 2015 | $12,176,000 | -38.7% | 119,800 | +7.6% | 0.12% | -35.2% |
| Q3 2015 | $19,852,000 | -6.6% | 111,300 | +16.3% | 0.18% | -13.7% |
| Q2 2015 | $21,259,000 | +15.0% | 95,700 | +2.8% | 0.21% | +14.1% |
| Q1 2015 | $18,493,000 | -64.8% | 93,100 | -74.6% | 0.18% | -61.1% |
| Q4 2014 | $52,550,000 | +3005.8% | 367,200 | +2746.5% | 0.48% | +2275.0% |
| Q3 2014 | $1,692,000 | – | 12,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |